Insight Inv LLC’s Elevance Health ELV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$626K Sell
1,618
-509
-24% -$189K 0.3% 63
2026
Q1
$623K Sell
2,127
-282
-12% -$92.7K 0.34% 65
2025
Q4
$844K Sell
2,409
-15
-0.6% -$5.07K 0.47% 61
2025
Q3
$783K Sell
2,424
-144
-6% -$44.8K 0.46% 62
2025
Q2
$999K Buy
2,568
+1
+0% +$402 0.67% 56
2025
Q1
$1.12M Buy
2,567
+10
+0.4% +$4.01K 0.77% 53
2024
Q4
$943K Sell
2,557
-156
-6% -$65.3K 0.66% 53
2024
Q3
$1.41M Sell
2,713
-32
-1% -$17.1K 1.18% 41
2024
Q2
$1.49M Buy
2,745
+100
+4% +$52.9K 1.29% 40
2024
Q1
$1.37M Hold
2,645
1.19% 43
2023
Q4
$1.25M Buy
2,645
+25
+1% +$11.6K 1.22% 41
2023
Q3
$1.21M Sell
2,620
-55
-2% -$24.9K 1.34% 38
2023
Q2
$1.19M Hold
2,675
1.22% 43
2023
Q1
$1.23M Sell
2,675
-100
-4% -$47.6K 1.33% 39
2022
Q4
$1.42M Sell
2,775
-50
-2% -$25.4K 1.44% 33
2022
Q3
$1.28M Hold
2,825
1.42% 31
2022
Q2
$1.36M Sell
2,825
-35
-1% -$17.3K 1.38% 33
2022
Q1
$1.41M Sell
2,860
-12
-0.4% -$5.49K 1.28% 37
2021
Q4
$1.33M Buy
+2,872
New +$1.21M 1.22% 38

Other funds holding ELV

Insight Inv LLC's ELV Position: Q2 2026 in Review

Insight Inv LLC reduced its Elevance Health (ELV) stake by 24% in Q2 2026, selling an estimated $189K and leaving 1,618 shares worth $626K. The position accounts for 0.3% of the portfolio, ranked #63.

Insight Inv LLC first reported a position in ELV in Q4 2021 and has held it in 19 quarters since. The position peaked at $1.49M in Q2 2024. 417 funds tracked by Wall St. Rank hold ELV as of Q2 2026.

  • Insight Inv LLC held 1,618 shares of Elevance Health worth $626K as of Q2 2026.
  • Insight Inv LLC sold 509 Elevance Health shares in Q2 2026, an estimated $189K.
  • Elevance Health made up 0.3% of Insight Inv LLC's portfolio in Q2 2026, its #63 holding.
  • Insight Inv LLC first reported a position in Elevance Health in Q4 2021 and has held it in 19 quarters since.
  • Insight Inv LLC's Elevance Health position peaked at $1.49M in Q2 2024.
  • 417 funds tracked by Wall St. Rank held Elevance Health as of Q2 2026.

Based on Insight Inv LLC's 13F filing for Q2 2026, filed 24 Jul 2026.